


Searching News Database: V2 Renal Denervation System
HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
HSMN NewsFeed - 12 Apr 2012
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
